WHO updates patent information on treatments for Hepatitis C
Visit the WHO website for updates on patent information on treatments for Hepatitis C
Visit the WHO website for updates on patent information on treatments for Hepatitis C
The lack of prequalified reproductive health medicines is of great concern to WHO and to partner organizations working to improve reproductive health.
To assist manufacturers in resource-limited countries who are keen to attain product prequalification, WHO-PQT is initiating a pilot collaboration whereby manufacturers can requ
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list
Laboratory added to the List of Prequalified Quality Control Laboratories (QCLs):
Product included:
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list
New addition:
Information for manufacturers who experience delays in national registrations of prequalified medicines
http://www.who.int/features/2013/accelerated_registration/en/
On 16 January 2013, an article entitled �Study questions generic HIV drug use� appeared on BBC News Health.
In a number of publications since July 2012 Roger Bate of the American Public Enterpris
This note outlines the basic principles applied by PQP for prioritization of product dossier assessments and inspections of related sites within each therapeutic area.
The product information is an essential part of the medicinal product. The SmPC and PIL published with the WHOPAR have been quality assured by WHO experts and reflect the si